Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

Next Generation iBOT

K-Number: K172601 · 2018-03-02

Decision Date2018-03-02
Product CodeIMK
Advisory CommitteePM
DecisionSubstantially Equivalent

Device Summary

Next Generation iBOT is the device name listed in this FDA 510(k) record. The listed applicant is Deka Research & Development Corp.. It received FDA 510(k) clearance on 2018-03-02 under 510(k) number K172601. The device is classified under product code IMK. It was reviewed by the PM advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the Next Generation iBOT?

Next Generation iBOT is a medical device that received FDA 510(k) clearance on 2018-03-02. The listed applicant is Deka Research & Development Corp.. The 510(k) number is K172601.

When did Next Generation iBOT receive FDA 510(k) clearance?

Next Generation iBOT received FDA 510(k) clearance on 2018-03-02, under 510(k) number K172601.

Who is the listed applicant for Next Generation iBOT?

The FDA 510(k) record lists Deka Research & Development Corp. as the applicant. This does not by itself establish the device manufacturer.

What is the FDA product code for Next Generation iBOT?

The FDA product code for Next Generation iBOT is IMK.

Other records listing Deka Research & Development Corp. as applicant

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

View all 7 devices →

Related Devices (Code: IMK)

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.